KPTI CIK: 1503802

Karyopharm Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−107
FY22:
−150
FY23:
−92.7
FY24:
−127
FY25:
−75.4
Change from FY21 to FY25
millions USD
FY21:
142
FY22:
−104
FY23:
7.94
FY24:
95.5
FY25:
43.4
Change from FY21 to FY25
millions USD
FY21:
73.6
FY22:
194
FY23:
1.12
FY24:
41.6
FY25:
30.0
millions USD
FY21:
108
FY22:
−60.6
FY23:
−83.7
FY24:
9.62
FY25:
−1.92
(positive)
Change from FY21 to FY25
millions USD
FY21:
−107
FY22:
−150
FY23:
−92.7
FY24:
−128
FY25:
−75.4

All amounts in millions USD Data source:SEC EDGAR